MEDICAL PROGRESS Renal Failure in Cirrhosis

被引：560

作者：

Gines, Pere ^{[2
,3
]}

Schrier, Robert W. ^{[1
]}

机构：

[1] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA

[2] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Barcelona, Catalonia, Spain

[3] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalonia, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 13期

关键词：

SPONTANEOUS BACTERIAL PERITONITIS; LIVER-KIDNEY TRANSPLANTATION; TYPE-1; HEPATORENAL-SYNDROME; INTERNATIONAL-ASCITES-CLUB; SERUM CREATININE; NITRIC-OXIDE; RISK-FACTORS; ADRENAL INSUFFICIENCY; TERLIPRESSIN THERAPY; CONSENSUS CONFERENCE;

D O I：

10.1056/NEJMra0809139

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Renal failure is a very common, severe complication in patients with decompensated cirrhosis and is a risk factor for a poor outcome of liver transplantation. Recently introduced therapies have demonstrated efficacy in the prevention and management of the hepatorenal syndrome, a particularly severe form of renal failure characteristic of cirrhosis. Use of these therapies in patients awaiting liver transplantation may help improve the outcome after transplantation. Copyright © 2009 Massachusetts Medical Society. All rights reserved.

引用

页码：1279 / 1290

页数：12

共 100 条

[41]

Grewal Priya, 2007, Clin Liver Dis, V11, P431, DOI 10.1016/j.cld.2007.04.009

[42] Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion [J].

Guevara, M ;

Ginès, P ;

Fernández-Esparrach, G ;

Sort, P ;

Salmerón, JM ;

Jiménez, W ;

Arroyo, V ;

Rodés, J .

HEPATOLOGY, 1998, 27 (01) :35-41

[43] Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine [J].

Gülberg, V ;

Bilzer, M ;

Gerbes, AL .

HEPATOLOGY, 1999, 30 (04) :870-875

[44] Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis [J].

Hampel, H ;

Bynum, GD ;

Zamora, E ;

El-Serag, HB .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) :2206-2210

[45] Urinary biomarkers in the early diagnosis of acute kidney injury [J].

Han, W. K. ;

Waikar, S. S. ;

Johnson, A. ;

Betensky, R. A. ;

Dent, C. L. ;

Devarajan, P. ;

Bonventre, J. V. .

KIDNEY INTERNATIONAL, 2008, 73 (07) :863-869

[46] Hepatorenal syndrome - Combined liver kidney transplants versus isolated liver transplant [J].

Jeyarajah, DR ;

Gonwa, TA ;

McBride, M ;

Testa, G ;

Abbasolgu, O ;

Husberg, BS ;

Levy, MF ;

Goldstein, RM ;

Klintmalm, GB .

TRANSPLANTATION, 1997, 64 (12) :1760-1765

[47] The Model for End-stage Liver Disease (MELD) [J].

Kamath, Patrick S. ;

Kim, W. Ray .

HEPATOLOGY, 2007, 45 (03) :797-805

[48] RISK-FACTORS AND OUTCOME OF 107 PATIENTS WITH DECOMPENSATED LIVER-DISEASE AND ACUTE-RENAL-FAILURE (INCLUDING 26 PATIENTS WITH HEPATORENAL-SYNDROME) - THE ROLE OF HEMODIALYSIS [J].

KELLER, F ;

HEINZE, H ;

JOCHIMSEN, F ;

PASSFALL, J ;

SCHUPPAN, D ;

BUTTNER, P .

RENAL FAILURE, 1995, 17 (02) :135-146

[49] Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study [J].

Kiser, TH ;

Fish, DN ;

Obritsch, MD ;

Jung, R ;

MacLaren, R ;

Parikh, CR .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) :1813-1820

[50] National Kidney Foundation practice guidelines for chronic kidney disease (vol 139, pg 137, 2003) [J].

Levey, AS ;

Coresh, J ;

Balk, E ;

Kausz, AT ;

Levin, A ;

Steffes, MW .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (07) :605-605

← 1 2 3 4 5 6 7 8 9 10 →